Official Journal of the Human Genome Organisation
Table 1 Egr-1, PDGF-A, and FA synthase expression in human diseases of epidermal proliferation
From: Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases
Human Tissue | No. specimens | ++ (% ) | + (%) | − (%) |
|---|---|---|---|---|
Egr-1 | ||||
Psoriasis | 20 | 70 | 6 | 24 |
BCC, nodular | 21 | 0 | 10 | 90 |
BCC, superficial | 16 | 0 | 12 | 88 |
BCC, morpheic | 18 | 0 | 17 | 83 |
SCC | 24 | 0 | 17 | 83 |
SCC in situ | 17 | 0 | 47 | 53 |
PDGF-A | ||||
Psoriasis | 20 | 100 | 0 | 0 |
BCC, nodular | 21 | 90 | 10 | 0 |
BCC, superficial | 16 | 100 | 0 | 0 |
BCC, morpheic | 18 | 89 | 11 | 0 |
SCC | 24 | 100 | 0 | 0 |
SCC in situ | 17 | 100 | 0 | 0 |
FA synthase | ||||
Psoriasis | 20 | 100 | 0 | 0 |
BCC, nodular | 21 | 0 | 5 | 95 |
BCC, superficial | 16 | 0 | 15 | 85 |
BCC, morpheic | 18 | 0 | 0 | 100 |
SCC | 24 | 4 | 8 | 88 |
SCC in situ | 17 | 6 | 0 | 94 |